Helicobacter pylori eradication protocols (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Helicobacter pylori eradication protocols" in English language version.

refsWebsite

Global rank English rank

23nih.gov

4^th place

18doi.org

2^nd place

4semanticscholar.org

11^th place

8^th place

1handle.net

102^nd place

76^th place

1archives-ouvertes.fr

1,031^st place

879^th place

1web.archive.org

1^st place

1mayoclinicproceedings.org

low place

1worldcat.org

5^th place

archives-ouvertes.fr

hal.archives-ouvertes.fr

Szajewska H, Horvath A, Piwowarczyk A (2010). "Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment". Aliment Pharmacol Ther. 32 (9): 1069–1079. doi:10.1111/j.1365-2036.2010.04457.x. PMID 21039671. Archived from the original on 2019-09-02. Retrieved 2019-09-02.

doi.org

Chan FK, To KF, Wu JC, Yung MY, Leung WK, Kwok T, Hui Y, Chan HL, Chan CS, Hui E, Woo J, Sung JJ (5 January 2002). "Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial". Lancet. 359 (9300): 9–13. doi:10.1016/s0140-6736(02)07272-0. PMID 11809180. S2CID 26114789.
Sonnenberg A (June 2007). "Time trends of ulcer mortality in Europe". Gastroenterology. 132 (7): 2320–7. doi:10.1053/j.gastro.2007.03.108. PMID 17570207.
Gatta L, Vakil N, Vaira D, Scarpignato C (7 August 2013). "Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy". BMJ (Clinical Research Ed.). 347: f4587. doi:10.1136/bmj.f4587. PMC 3736972. PMID 23926315.
Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, El-Omar EM, Kuipers EJ (5 April 2012). "Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report". Gut. 61 (5): 646–664. doi:10.1136/gutjnl-2012-302084. hdl:1765/64813. PMID 22491499.
Molina-Infante J, Romano M, Fernandez-Bermejo M, Federico A, Gravina AG, Pozzati L, Garcia-Abadia E, Vinagre-Rodriguez G, Martinez-Alcala C, Hernandez-Alonso M, Miranda A, Iovene MR, Pazos-Pacheco C, Gisbert JP (July 2013). "Optimized nonbismuth quadruple therapies cure most patients with Helicobacter pylori infection in populations with high rates of antibiotic resistance". Gastroenterology. 145 (1): 121–128.e1. doi:10.1053/j.gastro.2013.03.050. PMID 23562754.
Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ (June 2007). "Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report". Gut. 56 (6): 772–81. doi:10.1136/gut.2006.101634. PMC 1954853. PMID 17170018.
Wang H, Kong QZ, Li YY, Yang XY, Zuo XL (March 2024). "High-dose dual therapy versus bismuth-containing quadruple therapy for the eradication of Helicobacter pylori: A systematic review and meta-analysis". J Dig Dis. 25 (3): 163–175. doi:10.1111/1751-2980.13263. PMID 38577962.
Urgesi R, Cianci R, Riccioni ME (2012). "Update on triple therapy for eradication of Helicobacter pylori: current status of the art". Clinical and Experimental Gastroenterology. 5: 151–157. doi:10.2147/CEG.S25416. PMC 3449761. PMID 23028235.
Rimbara E, Fischbach LA, Graham DY (2011). "Optimal therapy for Helicobacter pylori infections". Nat. Rev. Gastroenterol. Hepatol. 8 (2): 79–88. doi:10.1038/nrgastro.2010.210. PMID 21293508. S2CID 23529476.
Zhou BG, Jiang X, Ding YB, She Q, Li YY (2024). "Vonoprazan-amoxicillin dual therapy versus bismuth-containing quadruple therapy for Helicobacter pylori eradication: A systematic review and meta-analysis". Helicobacter. 29 (1): e13040. doi:10.1111/hel.13040. PMID 37983865. S2CID 265308205.
Ren Q, Yan X, Zhou Y, Li WX (7 February 2016). "Periodontal therapy as adjunctive treatment for gastric Helicobacter pylori infection". The Cochrane Database of Systematic Reviews. 2016 (2): CD009477. doi:10.1002/14651858.CD009477.pub2. PMC 8255095. PMID 26852297.
Szajewska H, Horvath A, Piwowarczyk A (2010). "Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment". Aliment Pharmacol Ther. 32 (9): 1069–1079. doi:10.1111/j.1365-2036.2010.04457.x. PMID 21039671. Archived from the original on 2019-09-02. Retrieved 2019-09-02.
B Y, H A (2010). "Efficacy of probiotics in Helicobacter pylori eradication therapy". Turk J Gastroenterol. 21 (3): 212–217. doi:10.4318/tjg.2010.0090. PMID 20931422.
Kyle RA, Steensma DP, Shampo MA (2016-05-01). "Barry James Marshall—Discovery of Helicobacter pylori as a Cause of Peptic Ulcer". Mayo Clinic Proceedings. 91 (5): e67 – e68. doi:10.1016/j.mayocp.2016.01.025. ISSN 0025-6196.
Borody TJ, P. Cole, S. Noonan, A. Morgan, J. Lenne, L. Hyland, S. Brandl, E. G. Borody, L. L. George (October 16, 1989). "Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication". Medical Journal of Australia. 151 (8): 431–435. doi:10.5694/j.1326-5377.1989.tb101251.x. PMID 2687668. S2CID 26066525.
Mirbagheri SA, Mehrdad Hasibi, Mehdi Abouzari, Armin Rashidi (August 14, 2006). "Triple, standard quadruple and ampicillin–sulbactam-based quadruple therapies for H pylori eradication: A comparative three-armed randomized clinical trial". World Journal of Gastroenterology. 12 (30): 4888–4891. doi:10.3748/wjg.v12.i30.4888. PMC 4087627. PMID 16937475.
Cammarota G, Branca G, Ardito F, Sanguinetti M, Ianiro G, Cianci R, Torelli R, Masala G, Gasbarrini A, Fadda G, Landolfi R, Gasbarrini G (2010). "Biofilm Demolition and Antibiotic Treatment to Eradicate Resistant Helicobacter pylori: A Clinical Trial". Clinical Gastroenterology and Hepatology. 8 (9): 817–820.e3. doi:10.1016/j.cgh.2010.05.006. PMID 20478402.
Kanu JE, Soldera J (March 2024). "Treatment of Helicobacter pylori with potassium competitive acid blockers: A systematic review and meta-analysis". World J Gastroenterol. 30 (9): 1213–1223. doi:10.3748/wjg.v30.i9.1213. PMC 10989498. PMID 38577188.

handle.net

hdl.handle.net

Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, El-Omar EM, Kuipers EJ (5 April 2012). "Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report". Gut. 61 (5): 646–664. doi:10.1136/gutjnl-2012-302084. hdl:1765/64813. PMID 22491499.

mayoclinicproceedings.org

Kyle RA, Steensma DP, Shampo MA (2016-05-01). "Barry James Marshall—Discovery of Helicobacter pylori as a Cause of Peptic Ulcer". Mayo Clinic Proceedings. 91 (5): e67 – e68. doi:10.1016/j.mayocp.2016.01.025. ISSN 0025-6196.

nih.gov

pubmed.ncbi.nlm.nih.gov

Chan FK, To KF, Wu JC, Yung MY, Leung WK, Kwok T, Hui Y, Chan HL, Chan CS, Hui E, Woo J, Sung JJ (5 January 2002). "Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial". Lancet. 359 (9300): 9–13. doi:10.1016/s0140-6736(02)07272-0. PMID 11809180. S2CID 26114789.
Sonnenberg A (June 2007). "Time trends of ulcer mortality in Europe". Gastroenterology. 132 (7): 2320–7. doi:10.1053/j.gastro.2007.03.108. PMID 17570207.
Gatta L, Vakil N, Vaira D, Scarpignato C (7 August 2013). "Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy". BMJ (Clinical Research Ed.). 347: f4587. doi:10.1136/bmj.f4587. PMC 3736972. PMID 23926315.
Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, El-Omar EM, Kuipers EJ (5 April 2012). "Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report". Gut. 61 (5): 646–664. doi:10.1136/gutjnl-2012-302084. hdl:1765/64813. PMID 22491499.
Molina-Infante J, Romano M, Fernandez-Bermejo M, Federico A, Gravina AG, Pozzati L, Garcia-Abadia E, Vinagre-Rodriguez G, Martinez-Alcala C, Hernandez-Alonso M, Miranda A, Iovene MR, Pazos-Pacheco C, Gisbert JP (July 2013). "Optimized nonbismuth quadruple therapies cure most patients with Helicobacter pylori infection in populations with high rates of antibiotic resistance". Gastroenterology. 145 (1): 121–128.e1. doi:10.1053/j.gastro.2013.03.050. PMID 23562754.
Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ (June 2007). "Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report". Gut. 56 (6): 772–81. doi:10.1136/gut.2006.101634. PMC 1954853. PMID 17170018.
Wang H, Kong QZ, Li YY, Yang XY, Zuo XL (March 2024). "High-dose dual therapy versus bismuth-containing quadruple therapy for the eradication of Helicobacter pylori: A systematic review and meta-analysis". J Dig Dis. 25 (3): 163–175. doi:10.1111/1751-2980.13263. PMID 38577962.
Urgesi R, Cianci R, Riccioni ME (2012). "Update on triple therapy for eradication of Helicobacter pylori: current status of the art". Clinical and Experimental Gastroenterology. 5: 151–157. doi:10.2147/CEG.S25416. PMC 3449761. PMID 23028235.
Rimbara E, Fischbach LA, Graham DY (2011). "Optimal therapy for Helicobacter pylori infections". Nat. Rev. Gastroenterol. Hepatol. 8 (2): 79–88. doi:10.1038/nrgastro.2010.210. PMID 21293508. S2CID 23529476.
Zhou BG, Jiang X, Ding YB, She Q, Li YY (2024). "Vonoprazan-amoxicillin dual therapy versus bismuth-containing quadruple therapy for Helicobacter pylori eradication: A systematic review and meta-analysis". Helicobacter. 29 (1): e13040. doi:10.1111/hel.13040. PMID 37983865. S2CID 265308205.
Ren Q, Yan X, Zhou Y, Li WX (7 February 2016). "Periodontal therapy as adjunctive treatment for gastric Helicobacter pylori infection". The Cochrane Database of Systematic Reviews. 2016 (2): CD009477. doi:10.1002/14651858.CD009477.pub2. PMC 8255095. PMID 26852297.
Szajewska H, Horvath A, Piwowarczyk A (2010). "Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment". Aliment Pharmacol Ther. 32 (9): 1069–1079. doi:10.1111/j.1365-2036.2010.04457.x. PMID 21039671. Archived from the original on 2019-09-02. Retrieved 2019-09-02.
B Y, H A (2010). "Efficacy of probiotics in Helicobacter pylori eradication therapy". Turk J Gastroenterol. 21 (3): 212–217. doi:10.4318/tjg.2010.0090. PMID 20931422.
Borody TJ, P. Cole, S. Noonan, A. Morgan, J. Lenne, L. Hyland, S. Brandl, E. G. Borody, L. L. George (October 16, 1989). "Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication". Medical Journal of Australia. 151 (8): 431–435. doi:10.5694/j.1326-5377.1989.tb101251.x. PMID 2687668. S2CID 26066525.
Mirbagheri SA, Mehrdad Hasibi, Mehdi Abouzari, Armin Rashidi (August 14, 2006). "Triple, standard quadruple and ampicillin–sulbactam-based quadruple therapies for H pylori eradication: A comparative three-armed randomized clinical trial". World Journal of Gastroenterology. 12 (30): 4888–4891. doi:10.3748/wjg.v12.i30.4888. PMC 4087627. PMID 16937475.
Cammarota G, Branca G, Ardito F, Sanguinetti M, Ianiro G, Cianci R, Torelli R, Masala G, Gasbarrini A, Fadda G, Landolfi R, Gasbarrini G (2010). "Biofilm Demolition and Antibiotic Treatment to Eradicate Resistant Helicobacter pylori: A Clinical Trial". Clinical Gastroenterology and Hepatology. 8 (9): 817–820.e3. doi:10.1016/j.cgh.2010.05.006. PMID 20478402.
Kanu JE, Soldera J (March 2024). "Treatment of Helicobacter pylori with potassium competitive acid blockers: A systematic review and meta-analysis". World J Gastroenterol. 30 (9): 1213–1223. doi:10.3748/wjg.v30.i9.1213. PMC 10989498. PMID 38577188.

ncbi.nlm.nih.gov

Gatta L, Vakil N, Vaira D, Scarpignato C (7 August 2013). "Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy". BMJ (Clinical Research Ed.). 347: f4587. doi:10.1136/bmj.f4587. PMC 3736972. PMID 23926315.
Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ (June 2007). "Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report". Gut. 56 (6): 772–81. doi:10.1136/gut.2006.101634. PMC 1954853. PMID 17170018.
Urgesi R, Cianci R, Riccioni ME (2012). "Update on triple therapy for eradication of Helicobacter pylori: current status of the art". Clinical and Experimental Gastroenterology. 5: 151–157. doi:10.2147/CEG.S25416. PMC 3449761. PMID 23028235.
Ren Q, Yan X, Zhou Y, Li WX (7 February 2016). "Periodontal therapy as adjunctive treatment for gastric Helicobacter pylori infection". The Cochrane Database of Systematic Reviews. 2016 (2): CD009477. doi:10.1002/14651858.CD009477.pub2. PMC 8255095. PMID 26852297.
Mirbagheri SA, Mehrdad Hasibi, Mehdi Abouzari, Armin Rashidi (August 14, 2006). "Triple, standard quadruple and ampicillin–sulbactam-based quadruple therapies for H pylori eradication: A comparative three-armed randomized clinical trial". World Journal of Gastroenterology. 12 (30): 4888–4891. doi:10.3748/wjg.v12.i30.4888. PMC 4087627. PMID 16937475.
Kanu JE, Soldera J (March 2024). "Treatment of Helicobacter pylori with potassium competitive acid blockers: A systematic review and meta-analysis". World J Gastroenterol. 30 (9): 1213–1223. doi:10.3748/wjg.v30.i9.1213. PMC 10989498. PMID 38577188.

semanticscholar.org

api.semanticscholar.org

Chan FK, To KF, Wu JC, Yung MY, Leung WK, Kwok T, Hui Y, Chan HL, Chan CS, Hui E, Woo J, Sung JJ (5 January 2002). "Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial". Lancet. 359 (9300): 9–13. doi:10.1016/s0140-6736(02)07272-0. PMID 11809180. S2CID 26114789.
Rimbara E, Fischbach LA, Graham DY (2011). "Optimal therapy for Helicobacter pylori infections". Nat. Rev. Gastroenterol. Hepatol. 8 (2): 79–88. doi:10.1038/nrgastro.2010.210. PMID 21293508. S2CID 23529476.
Zhou BG, Jiang X, Ding YB, She Q, Li YY (2024). "Vonoprazan-amoxicillin dual therapy versus bismuth-containing quadruple therapy for Helicobacter pylori eradication: A systematic review and meta-analysis". Helicobacter. 29 (1): e13040. doi:10.1111/hel.13040. PMID 37983865. S2CID 265308205.
Borody TJ, P. Cole, S. Noonan, A. Morgan, J. Lenne, L. Hyland, S. Brandl, E. G. Borody, L. L. George (October 16, 1989). "Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication". Medical Journal of Australia. 151 (8): 431–435. doi:10.5694/j.1326-5377.1989.tb101251.x. PMID 2687668. S2CID 26066525.

web.archive.org

Szajewska H, Horvath A, Piwowarczyk A (2010). "Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment". Aliment Pharmacol Ther. 32 (9): 1069–1079. doi:10.1111/j.1365-2036.2010.04457.x. PMID 21039671. Archived from the original on 2019-09-02. Retrieved 2019-09-02.

worldcat.org

search.worldcat.org

Kyle RA, Steensma DP, Shampo MA (2016-05-01). "Barry James Marshall—Discovery of Helicobacter pylori as a Cause of Peptic Ulcer". Mayo Clinic Proceedings. 91 (5): e67 – e68. doi:10.1016/j.mayocp.2016.01.025. ISSN 0025-6196.